<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药融投资 | wechat-feeds</title><link>http://Mzg5OTA1NDgzMg.favicon.privacyhide.com/favicon.ico</link><description>医药行业</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 25 Jan 2021 23:35:12 +0800</pubDate><image><url>http://Mzg5OTA1NDgzMg.favicon.privacyhide.com/favicon.ico</url><title>药融投资 | wechat-feeds</title><link>http://Mzg5OTA1NDgzMg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>【官宣】丹诺医药与强生达成抗感染新药合作</title><link>https://mp.weixin.qq.com/s/zE9o6o6vdkGN2sa18TzRzQ</link><description></description><content:encoded><![CDATA[【官宣】丹诺医药与强生达成抗感染新药合作]]></content:encoded><pubDate>Mon, 18 Jan 2021 14:41:46 +0800</pubDate></item><item><title>mRNA赛道热潮：沃森投不进去的艾博生物是什么情况？</title><link>https://mp.weixin.qq.com/s/nTAYtxeXMDYScyz0L65IPA</link><description></description><content:encoded><![CDATA[mRNA赛道热潮：沃森投不进去的艾博生物是什么情况？]]></content:encoded><pubDate>Mon, 18 Jan 2021 14:41:46 +0800</pubDate></item><item><title>国内Biotech Top:1100亿再鼎医药的内部研发管线</title><link>https://mp.weixin.qq.com/s/ZfbhDGq7XdvBJl9-k-7XVg</link><description></description><content:encoded><![CDATA[国内Biotech Top:1100亿再鼎医药的内部研发管线]]></content:encoded><pubDate>Fri, 15 Jan 2021 13:50:11 +0800</pubDate></item><item><title>盟科上市辅导：抗感染新药第一股</title><link>https://mp.weixin.qq.com/s/nsdIx12PVlFwpKTeASCVZg</link><description></description><content:encoded><![CDATA[盟科上市辅导：抗感染新药第一股]]></content:encoded><pubDate>Thu, 14 Jan 2021 16:46:42 +0800</pubDate></item><item><title>特色医药供应商/CDMO：毕得医药辅导上市</title><link>https://mp.weixin.qq.com/s/1j_Z4M7PLxPPnt1RSGKOKQ</link><description></description><content:encoded><![CDATA[特色医药供应商/CDMO：毕得医药辅导上市]]></content:encoded><pubDate>Thu, 14 Jan 2021 16:46:42 +0800</pubDate></item><item><title>Biotech Top：信达生物市值1340亿；全球研发中心落上海</title><link>https://mp.weixin.qq.com/s/AXcgLtHS_IHDdI6JGg01tg</link><description></description><content:encoded><![CDATA[Biotech Top：信达生物市值1340亿；全球研发中心落上海]]></content:encoded><pubDate>Thu, 14 Jan 2021 16:32:26 +0800</pubDate></item><item><title>国内首个CAR-T疗法！复星凯特「益基利仑赛注射液」即将获批上市</title><link>https://mp.weixin.qq.com/s/3zwwQr-f7miG_MjaQHXBng</link><description></description><content:encoded><![CDATA[国内首个CAR-T疗法！复星凯特「益基利仑赛注射液」即将获批上市]]></content:encoded><pubDate>Thu, 14 Jan 2021 16:32:26 +0800</pubDate></item><item><title>益方生物科创板辅导中：KRAS美国已临床启动</title><link>https://mp.weixin.qq.com/s/hw2F4tya4LbCJCr4zriyFA</link><description></description><content:encoded><![CDATA[益方生物科创板辅导中：KRAS美国已临床启动]]></content:encoded><pubDate>Mon, 11 Jan 2021 13:35:22 +0800</pubDate></item><item><title>琅琊榜—2020年CXO公司国际化程度排排坐</title><link>https://mp.weixin.qq.com/s/YASET-PJm2wdKJWMQL6Q7Q</link><description></description><content:encoded><![CDATA[琅琊榜—2020年CXO公司国际化程度排排坐]]></content:encoded><pubDate>Mon, 11 Jan 2021 13:35:22 +0800</pubDate></item><item><title>自身免疫新兵：创响生物与和黄达成2.3亿美元合作</title><link>https://mp.weixin.qq.com/s/IdhXSgSC5Mkq6-yMsddLvw</link><description></description><content:encoded><![CDATA[自身免疫新兵：创响生物与和黄达成2.3亿美元合作]]></content:encoded><pubDate>Mon, 11 Jan 2021 13:28:23 +0800</pubDate></item><item><title>药融圈发布：男女均有效！开拓药业普克鲁胺阻止新冠患者轻症向重症转化，效果显著</title><link>https://mp.weixin.qq.com/s/lLP38ji99XA95HRV4PQS7A</link><description></description><content:encoded><![CDATA[药融圈发布：男女均有效！开拓药业普克鲁胺阻止新冠患者轻症向重症转化，效果显著]]></content:encoded><pubDate>Mon, 11 Jan 2021 13:28:23 +0800</pubDate></item><item><title>【产业观察】以为小适应症，结果TRK新药大热门</title><link>https://mp.weixin.qq.com/s/4JRG1Oz5OEvG16O2ZfK2Ww</link><description></description><content:encoded><![CDATA[【产业观察】以为小适应症，结果TRK新药大热门]]></content:encoded><pubDate>Mon, 11 Jan 2021 13:28:23 +0800</pubDate></item><item><title>药融圈发布：小分子新锐再极医药完成近2亿融资</title><link>https://mp.weixin.qq.com/s/yzlOJbDWtA5FfMUPtdzAOg</link><description></description><content:encoded><![CDATA[药融圈发布：小分子新锐再极医药完成近2亿融资]]></content:encoded><pubDate>Wed, 06 Jan 2021 09:21:37 +0800</pubDate></item><item><title>零度下的思考，差异化的机遇—未来10年医药业7大变局</title><link>https://mp.weixin.qq.com/s/u8skAyvhT5klPjFbJnKPKQ</link><description></description><content:encoded><![CDATA[零度下的思考，差异化的机遇—未来10年医药业7大变局]]></content:encoded><pubDate>Wed, 06 Jan 2021 09:21:37 +0800</pubDate></item><item><title>布局代谢及免疫：诚益生物完成新一轮超亿元融资</title><link>https://mp.weixin.qq.com/s/RkRnXoOJ27Ge-O6Q0-ilaQ</link><description></description><content:encoded><![CDATA[布局代谢及免疫：诚益生物完成新一轮超亿元融资]]></content:encoded><pubDate>Tue, 22 Dec 2020 09:20:22 +0800</pubDate></item><item><title>诺华siRNA新药获批：革命性降脂药物，一年仅2针的PCSK9</title><link>https://mp.weixin.qq.com/s/bh-uC8cITM72_n8313-C6Q</link><description></description><content:encoded><![CDATA[诺华siRNA新药获批：革命性降脂药物，一年仅2针的PCSK9]]></content:encoded><pubDate>Tue, 22 Dec 2020 09:20:22 +0800</pubDate></item><item><title>宇宙大药厂：辉瑞Pipeline解析，目前92项火热在研</title><link>https://mp.weixin.qq.com/s/cmaQxZJG4l8hv97s96ml1g</link><description></description><content:encoded><![CDATA[宇宙大药厂：辉瑞Pipeline解析，目前92项火热在研]]></content:encoded><pubDate>Mon, 21 Dec 2020 11:05:11 +0800</pubDate></item><item><title>科创板之风下：盟科药业完成7亿融资</title><link>https://mp.weixin.qq.com/s/yM20N1A23jRRxQK-gajA3A</link><description></description><content:encoded><![CDATA[科创板之风下：盟科药业完成7亿融资]]></content:encoded><pubDate>Mon, 21 Dec 2020 11:05:11 +0800</pubDate></item><item><title>门冬胰岛素30注射液首家国产：中国胰岛素之王的全球创新之路</title><link>https://mp.weixin.qq.com/s/Rsrgtdle00ui9z-bDx72Pg</link><description></description><content:encoded><![CDATA[门冬胰岛素30注射液首家国产：中国胰岛素之王的全球创新之路]]></content:encoded><pubDate>Tue, 15 Dec 2020 13:38:35 +0800</pubDate></item><item><title>最贵原料药之一：药化界珠穆朗玛峰，艾立布林</title><link>https://mp.weixin.qq.com/s/kUR2EC-WYSjvn3rr-0KGDg</link><description></description><content:encoded><![CDATA[最贵原料药之一：药化界珠穆朗玛峰，艾立布林]]></content:encoded><pubDate>Tue, 15 Dec 2020 13:38:35 +0800</pubDate></item></channel></rss>